Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. - Wikidata - awgldk - TriplyDB

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

http://www.wikidata.org/entity/Q36130821

about

Diabetic Cardiovascular Disease Induced by Oxidative Stress You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging The adventitia: essential regulator of vascular wall structure and function Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria Anti-peroxynitrite treatment ameliorated vasorelaxation of resistance arteries in aging rats: involvement with NO-sGC-cGKs pathway Tempol intake improves inflammatory status in aged mice.Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice.Mitochondrial quality control and age-associated arterial stiffening.The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice Superoxide signaling in perivascular adipose tissue promotes age-related artery stiffness.Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice Peroxisome proliferator-activated receptor-γ protects against vascular aging.Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury.Curcumin ameliorates arterial dysfunction and oxidative stress with aging.Large elastic artery stiffness with aging: novel translational mechanisms and interventions.Pharmacological Strategies to Retard Cardiovascular Aging The autophagy enhancer spermidine reverses arterial aging Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults.Aging impairs electrical conduction along endothelium of resistance arteries through enhanced Ca2+-activated K+ channel activation.Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice.Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience.Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice.Interleukin-10 protects against aging-induced endothelial dysfunction.The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD Oxidative stress in apoptosis and cancer: an update.Spreading the signal for vasodilatation: implications for skeletal muscle blood flow control and the effects of ageing.Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage.Practical alternatives to chronic caloric restriction for optimizing vascular function with ageing.Endoplasmic reticulum stress and the development of endothelial dysfunction.Long-term culture and functionality of pancreatic islets monitored using microelectrode arrays.ERK5/HDAC5-mediated, resveratrol-, and pterostilbene-induced expression of MnSOD in human endothelial cells.Tempol protects human lymphocytes from genotoxicity induced by cisplatin.Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress.Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells.Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging.Advanced age protects microvascular endothelium from aberrant Ca(2+) influx and cell death induced by hydrogen peroxide.

P2860

Q26778017-141966F8-A2E3-4149-8349-A991BB163A2D Q26824357-E33D28D4-37C4-4B88-A7B1-1F1759759AF9 Q27000503-5C025A12-CC59-4566-B0C9-3A5FE7E4FBC3 Q28386613-BB52A030-E18A-4BCE-9B69-F69D9A19FA02 Q28541815-6A5BAD6A-C1DA-4E8E-8CB8-107524060E15 Q33832066-AD519265-D7A7-4793-9608-03E662E58DFD Q34046440-4F48FE96-31F1-4D9A-B2BB-D38CBD546D01 Q34613192-200E4A64-11BF-4744-8413-1EF0C72DEFCA Q34726907-9E2B864B-91CE-4CCD-A25E-CF7EF4E93016 Q35080513-3DD8A9A9-FCBF-4C82-B03D-C616E021A604 Q35560446-61EB788D-B2D4-4EF1-8B87-1EE00F89CEAF Q35671757-FE28A415-54E6-447A-BDB9-487804AE0A61 Q35994295-A46E0ED6-F2DB-4BFA-8538-4636E347E765 Q36056243-ED27B9C9-55E4-495C-B606-25AA11AB203A Q36339948-D8611CFA-C32E-492B-B1AD-3B7BABA69070 Q36570080-2E14CEFA-C6DE-4EF2-9030-2EC364DBB1BA Q36859922-C85CFF59-E9A1-4E40-9DF9-96CDCB4E6BBD Q36972415-1B98C459-262A-475E-B336-FA3011610645 Q36980246-3503D8DB-A7B8-4321-9B44-AF2A0ECCDF30 Q37062435-13ADF3D9-E1CB-48AF-A6CF-24A72994B07B Q37161071-678CF6EB-5A21-4FAC-9D9F-70CA04EEB4D3 Q37170519-60C45AD9-29B9-41A5-A0CB-EDE6F6021536 Q37219252-2C683F1A-4ACD-4F80-8D04-49F1F7244A42 Q37322066-510B5194-39C3-4420-AAEF-F67ABC2BF4BD Q37342163-C96672BA-AF27-42B6-B6B1-2A19FA3FA250 Q37411080-4433E5DC-0E95-431B-9905-703460CD102D Q37552213-777CD05D-B1BE-4132-BBBF-5D755A832AC8 Q38027434-3A6B3BDC-2FD8-46E0-B85B-5DDD8F99A3C9 Q38034464-37C5C309-7167-44BF-9700-BE2F0F456B4C Q38339672-E3C4E8D9-81C0-4823-9C5C-D17CC99C74DF Q38597973-00C2C5EB-6291-4D28-A9F9-CE3750EBF186 Q38957934-03C37E10-9D5C-4D01-BA63-639423880893 Q39031005-FDC08CE1-C8A1-4BA3-9174-E07AA3FA8F2F Q39224948-420DCE49-9627-4144-9905-013547309C2E Q40459184-BC00B35B-7C48-41EC-8400-BCF585FC2B46 Q40714885-DA7A1B60-FBC8-48E5-92E3-9D7503378C09 Q41008506-2632A5DF-446B-46DB-9A90-79C79748CEC5 Q41247478-0410988E-F54C-476E-8D40-2FD17DD74F9F Q41412735-E435627B-C10C-494E-AFC9-FFF276338C6A Q42473055-A9F49017-F102-4B35-AD20-A7B6B48E08A1

P2860

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

http://www.wikidata.org/entity/Q36130821

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@ast

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@en

type

label

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@ast

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@en

prefLabel

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@ast

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@en

P1433

Q36130821-346C8D76-8433-4B25-99AA-DED17F5147AD

P1476

Q36130821-1A802E2E-7B9C-4D9A-B8AD-AF06F2512822

P2093

Q36130821-0DAC14D4-C511-40D5-8553-0A29F573F444

Q36130821-1CA0C0EE-94AF-4F7D-B6C7-D828CCA4C35C

Q36130821-31EF467F-EE2E-4A8E-AD9A-5F66B688125F

Q36130821-966914C9-9921-4499-9080-22AD75FC54E5

P2860

Q36130821-06E76F1E-E68B-4ECC-AC98-E5D5A36B0BB6

Q36130821-087493A2-7A1D-4006-8379-05DCB0C8AC3A

Q36130821-0E014473-6973-4D9E-9635-83F8FD7ECB27

Q36130821-242A181B-F51F-4A2A-AC6E-3130816BDEC1

Q36130821-25B6A05F-34E3-48F8-B86A-C9DB36000C58

Q36130821-2653AAFF-FB77-49F1-B845-B78901441BDD

Q36130821-26864BEB-FD15-49F8-8A2E-A44D265298CA

Q36130821-3673B257-C15E-4843-BBD2-F4F4284AFF22

Q36130821-40C84A18-E77D-45C5-B81E-557291BC33E4

Q36130821-4892041A-5BD5-440D-9D01-C44FCC7346DE

P304

Q36130821-5098DDF2-433A-417C-9A74-346375A00696

P31

Q36130821-E547750E-53CA-4E68-A2FB-4EB8F89A8C51

P356

Q36130821-39FD2785-F15D-4733-ABBB-BD5204CB3BF9

P433

Q36130821-F96EA462-17D8-4AA0-BAD5-419B0C55284C

P478

Q36130821-D94EADE3-E570-4FC3-830C-959B1103E239

P577

Q36130821-F05317C2-91B8-4F86-97FA-0087CD942592

P5875

Q36130821-65CE59D3-911F-497F-B9F0-04E5E745BCE3

P698

Q36130821-309A61B9-DF60-4D8D-9B1D-ABD3D5FF7966

P932

Q36130821-DDEEB59C-E7A7-4E44-990D-25AAF3839009

P356

J.1474-9726.2011.00783.X

P1433

P1476

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

@en

P2093

Amy L Sindler

http://www.w3.org/2001/XMLSchema#string

Bradley S Fleenor

http://www.w3.org/2001/XMLSchema#string

Douglas R Seals

http://www.w3.org/2001/XMLSchema#string

Melanie L Zigler

http://www.w3.org/2001/XMLSchema#string

P2860

Arterial stiffness and extracellular matrix

Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction.

Arterial stiffness and cardiovascular events: the Framingham Heart Study

Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress.

Mechanisms of vascular aging: new perspectives.

Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice.

Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging.

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Aerobic exercise reverses arterial inflammation with aging in mice.

P304

269-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1474-9726.2011.00783.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51877203

http://www.w3.org/2001/XMLSchema#string

P698

22168264

http://www.w3.org/2001/XMLSchema#string

P932

3409251

http://www.w3.org/2001/XMLSchema#string